Skip to Content
Coefficient Giving
Funds

Global Health & Wellbeing Opportunities

We support evidence-backed interventions to improve health and wellbeing for people around the world.

  • 360+
    grants made
  • $1.3+
    billion given

Contents

About the Fund

Team

Partners

Interested in learning more or joining the fund? Reach out to partnerwithus@coefficientgiving.org.

We believe every person’s life has intrinsic value regardless of where they were born. Across our funds that focus on global health and development, we support work that improves the lives of the world’s poorest people — who often live on a few dollars a day and lack access to basic necessities like clean water, sanitation, or healthcare. The work we fund ranges from reliable, cost-effective interventions, like distributing medication, to more ambitious interventions like advocating for policy change to improve economic conditions.

Most of this fund’s spending supports organizations recommended by GiveWell, with whom we have a close relationship. GiveWell looks for opportunities with a strong evidence base, successful track record, and low risk of failure (relative to our usual hits-based giving approach). Its previous recommendations include charities working on:

  • Malaria control: distributing bednets and antimalarial medicine in high-prevalence areas.
  • Clean water access: providing in-line chlorination technology to rural villages.
  • Vaccination programs: supporting work to develop and distribute life-saving vaccines, and to help parents keep up with vaccination schedules.

This fund also makes more leveraged grants — higher risk, higher potential upside — in areas that fall outside of the scope of our other funds, including areas recommended by our cause prioritization researchers where we may want to launch a fund later. (We followed this process for our Global Growth Fund.)

  • In October 2023, we committed $300 million over three years to GiveWell’s evidence-backed, cost-effective recommendations in global health and development. We recently decided to renew that funding early and increase it, committing an additional $175 million for 2026. This funding adds to the more than $1 billion we have previously committed to GiveWell’s recommendations.

    Read more

  • This is a shallow investigation of hepatitis delta, written by Douglas Chukwu Junior on our GHW Cause Prioritization team. His goal was to estimate the disease burden attributable to the condition, learn about barriers to addressing it, and identify potential funding opportunities.

    Read more

  • This is a shallow investigation of antimicrobial resistance, written by Deena Mousa on our GHW Cause Prioritization team. Her goal was to estimate the disease burden attributable to the condition, learn about barriers to addressing it, and identify potential funding opportunities.

    Read more

  • This 2017 essay outlines our early approach to global humanitarianism — the view that people have intrinsic value regardless of the circumstances of their birth (and that animals’ lives have value, too).

    Read more